Hering David 4
4 · Adagio Therapeutics, Inc. · Filed Jul 6, 2022
Insider Transaction Report
Form 4
Hering David
Chief Operating Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-07-05+2,000,000→ 2,000,000 totalExercise: $3.37Exp: 2032-07-04→ Common Stock (2,000,000 underlying)
Footnotes (1)
- [F1]This option vests in equal monthly installments over a period of 48 months with the first vesting date occurring on August 5, 2022, subject to the Reporting Person's continuous service as of the applicable vesting date.